WO1996041627A3 - Iron compounds, compositions, methods of making the same and uses thereof - Google Patents

Iron compounds, compositions, methods of making the same and uses thereof Download PDF

Info

Publication number
WO1996041627A3
WO1996041627A3 PCT/GB1996/001382 GB9601382W WO9641627A3 WO 1996041627 A3 WO1996041627 A3 WO 1996041627A3 GB 9601382 W GB9601382 W GB 9601382W WO 9641627 A3 WO9641627 A3 WO 9641627A3
Authority
WO
WIPO (PCT)
Prior art keywords
making
methods
compositions
same
iron compounds
Prior art date
Application number
PCT/GB1996/001382
Other languages
French (fr)
Other versions
WO1996041627A2 (en
Inventor
Michael Arthur Stockham
Robert Charles Hider
Original Assignee
Vitra Pharmaceuticals Ltd
Michael Arthur Stockham
Robert Charles Hider
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9511818.8A external-priority patent/GB9511818D0/en
Priority claimed from GBGB9517537.8A external-priority patent/GB9517537D0/en
Application filed by Vitra Pharmaceuticals Ltd, Michael Arthur Stockham, Robert Charles Hider filed Critical Vitra Pharmaceuticals Ltd
Priority to AU60106/96A priority Critical patent/AU6010696A/en
Priority to AT96917578T priority patent/ATE273702T1/en
Priority to EP96917578A priority patent/EP0833627B1/en
Priority to DE69633178T priority patent/DE69633178T2/en
Publication of WO1996041627A2 publication Critical patent/WO1996041627A2/en
Publication of WO1996041627A3 publication Critical patent/WO1996041627A3/en
Priority to US08/987,084 priority patent/US6339080B1/en
Priority to US09/983,656 priority patent/US6635631B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62Three oxygen atoms, e.g. ascorbic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Soft Magnetic Materials (AREA)
  • Hard Magnetic Materials (AREA)

Abstract

The present invention is directed to complexes comprising iron in the ferric state and a hydroxypyrone. The present invention is also directed to methods of making such complexes and to the use of such complexes in the treatment and prevention of iron deficiency disorders including iron deficiency anaemia.
PCT/GB1996/001382 1995-06-10 1996-06-10 Iron compounds, compositions, methods of making the same and uses thereof WO1996041627A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU60106/96A AU6010696A (en) 1995-06-10 1996-06-10 Iron compounds, compositions, methods of making the same and uses thereof
AT96917578T ATE273702T1 (en) 1995-06-10 1996-06-10 IRON COMPOUNDS, COMPOSITIONS, PRODUCTION PROCESSES AND USES THEREOF
EP96917578A EP0833627B1 (en) 1995-06-10 1996-06-10 Iron compounds, compositions, methods of making the same and uses thereof
DE69633178T DE69633178T2 (en) 1995-06-10 1996-06-10 Iron compounds, compositions, methods of preparation and uses thereof
US08/987,084 US6339080B1 (en) 1995-06-10 1997-12-09 Iron compounds, compositions, methods of making the same and uses thereof
US09/983,656 US6635631B2 (en) 1995-06-10 2001-10-25 Iron compounds, compositions, methods of making the same and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9511818.8 1995-06-10
GBGB9511818.8A GB9511818D0 (en) 1995-06-10 1995-06-10 Iron compounds compositions and uses thereof
GBGB9517537.8A GB9517537D0 (en) 1995-08-26 1995-08-26 Iron compounds, compositions and uses thereof
GB9517537.8 1995-08-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US08/987,084 Continuation US6339080B1 (en) 1995-06-10 1997-12-09 Iron compounds, compositions, methods of making the same and uses thereof

Publications (2)

Publication Number Publication Date
WO1996041627A2 WO1996041627A2 (en) 1996-12-27
WO1996041627A3 true WO1996041627A3 (en) 1997-03-13

Family

ID=26307198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/001382 WO1996041627A2 (en) 1995-06-10 1996-06-10 Iron compounds, compositions, methods of making the same and uses thereof

Country Status (7)

Country Link
US (2) US6339080B1 (en)
EP (1) EP0833627B1 (en)
AT (1) ATE273702T1 (en)
AU (1) AU6010696A (en)
DE (1) DE69633178T2 (en)
ES (1) ES2230564T3 (en)
WO (1) WO1996041627A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2230564T3 (en) 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. FERRIC COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE OF THESE AND ITS USED.
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
AU2001287850A1 (en) 2000-09-19 2002-04-02 Vitra Pharmaceuticals Limited Iron compositions
RU2209062C1 (en) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Substance of sedative action
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
US20070270591A1 (en) * 2006-05-16 2007-11-22 Ashmead H Dewayne Iron (II) amino acid chelates with reducing agents attached thereto
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
CN103865390A (en) * 2012-12-18 2014-06-18 锜玮科技(深圳)有限公司 Hydrophobic film-coating liquid and production process of anti-pollution anti-fingerprint film-coated layer prepared therefrom
ES2785391T3 (en) 2014-01-06 2020-10-06 Shield Tx Uk Ltd Ferric Trimaltol Dosage Regimen
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB201418710D0 (en) * 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
CN115177625A (en) * 2022-06-28 2022-10-14 金陵药业股份有限公司 Carboxyl ferric maltose pharmaceutical composition and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592889A (en) * 1966-12-15 1971-07-13 Astra Ab Process for the production of an intramuscularly injectable iron preparation for animals
EP0159194A2 (en) * 1984-04-19 1985-10-23 National Research Development Corporation Iron 3-hydroxypyrone or 3-hydroxypyridone complexes and pharmaceutical compositions containing them
EP0159917A2 (en) * 1984-04-19 1985-10-30 National Research Development Corporation Pharmaceutical composition containing a hydroxypyrone-iron complex
US4665064A (en) * 1983-10-31 1987-05-12 National Research Development Corporation Pharmaceutical compositions and methods for increasing zinc levels
JPH0367565A (en) * 1989-08-07 1991-03-22 Kansai Paint Co Ltd Iron-enriched food

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (en) * 1963-09-19 1969-04-10 Pfizer & Co C Process for the preparation of pyromeconic acid derivatives
US4018907A (en) 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4279936A (en) 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
GR78491B (en) 1982-03-24 1984-09-27 Nat Res Dev
CY1501A (en) 1982-03-24 1990-08-03 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or-4-one derivatives
GB2128998B (en) 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
GB8308054D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
ES2230564T3 (en) 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. FERRIC COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE OF THESE AND ITS USED.
GB9621273D0 (en) * 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592889A (en) * 1966-12-15 1971-07-13 Astra Ab Process for the production of an intramuscularly injectable iron preparation for animals
US4665064A (en) * 1983-10-31 1987-05-12 National Research Development Corporation Pharmaceutical compositions and methods for increasing zinc levels
EP0159194A2 (en) * 1984-04-19 1985-10-23 National Research Development Corporation Iron 3-hydroxypyrone or 3-hydroxypyridone complexes and pharmaceutical compositions containing them
EP0159917A2 (en) * 1984-04-19 1985-10-30 National Research Development Corporation Pharmaceutical composition containing a hydroxypyrone-iron complex
JPH0367565A (en) * 1989-08-07 1991-03-22 Kansai Paint Co Ltd Iron-enriched food

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. EL-JAMMAL ET AL.: "Reversed-phase high-performance liquid chromatography of non-transferrin bound iron and some hydroxypyridone and hydroxypyrone chelators", J. CHROMATOGR., B: BIOMED. APPL., vol. 658, no. 1, 1994, pages 121 - 127, XP002013889 *
DATABASE WPI Section Ch Week 9118, Derwent World Patents Index; Class D13, AN 91-128755, XP002013890 *

Also Published As

Publication number Publication date
US6635631B2 (en) 2003-10-21
EP0833627B1 (en) 2004-08-18
DE69633178D1 (en) 2004-09-23
ES2230564T3 (en) 2005-05-01
ATE273702T1 (en) 2004-09-15
AU6010696A (en) 1997-01-09
US20030069218A1 (en) 2003-04-10
WO1996041627A2 (en) 1996-12-27
EP0833627A2 (en) 1998-04-08
US6339080B1 (en) 2002-01-15
DE69633178T2 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
WO1996041627A3 (en) Iron compounds, compositions, methods of making the same and uses thereof
AU2291097A (en) Novel phenanthridines substituted in the 6 position
AU6964796A (en) Iron dextran formulations
DE69332469D1 (en) METAL COMPLEXES OF WATER-SOLUBLE TEXAPHYRINES
GEP20074185B (en) Incclusion complexs of aryl- heterocyclic salts
CA2077812A1 (en) Web dressing and method for its production
CA2268321A1 (en) Use of metal complexes to treat gastrointestinal infections
CA2199844A1 (en) Compositions for the treatment of skin disorders
AU2001287850A1 (en) Iron compositions
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
AU6682594A (en) Treatment of septic shock
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain
CA2144728A1 (en) Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
BG102667A (en) Diosgenine-containing composition
AU2157297A (en) Pharmaceutical combined preparations containing erythropoietin and iron preparations
CA2293808A1 (en) Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
MX9700624A (en) Imidazopyridine-azolidinones.
AU1214792A (en) Chelates, their metal complexes as well as their use in diagnosis and treatment
CA2162666A1 (en) Psyllium Drink Mix Compositions
HUT75529A (en) Use of dimeticone for treating constipation
BG102087A (en) The use of pyrrolidine derivatives for the treatment of alcoholism
CA2149766A1 (en) Rectal flunisolide compositions for treating inflammatory intestinal disorders
AU5760596A (en) Component b as cicatrizant
CA2177955A1 (en) Use of dimeticone for treating constipation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 08987084

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1996917578

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996917578

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1996917578

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)